Jesper F. Lau,Thomas Kruse,Henning Thoegersen,Thomas N. Krogh,Ulrich Sensfuss
申请号：
US14814686
公开号：
US20150368313A1
申请日:
2015.07.31
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present invention relates to novel glucagon peptides with improved stability and solubility at neutral pH, to the use of the compounds in therapy, to methods of treatment comprising administration of the compounds to patients in need thereof, and to the use of the compounds in the manufacture of medicaments. The glucagon peptides of the invention are of particular interest in relation to the treatment of hyperglycemia, diabetes and obesity, as well as a variety of diseases or conditions associated with hyperglycemia, diabetes and obesity.
